301 related articles for article (PubMed ID: 17588333)
21. Antiviral efficacy against hepatitis B virus replication of oleuropein isolated from Jasminum officinale L. var. grandiflorum.
Zhao G; Yin Z; Dong J
J Ethnopharmacol; 2009 Sep; 125(2):265-8. PubMed ID: 19580857
[TBL] [Abstract][Full Text] [Related]
22. HSPB1 is an intracellular antiviral factor against hepatitis B virus.
Tong SW; Yang YX; Hu HD; An X; Ye F; Ren H; Li SL; Zhang DZ
J Cell Biochem; 2013 Jan; 114(1):162-73. PubMed ID: 22887120
[TBL] [Abstract][Full Text] [Related]
23. Antiviral effect of Phyllanthus nanus ethanolic extract against hepatitis B virus (HBV) by expression microarray analysis.
Lam WY; Leung KT; Law PT; Lee SM; Chan HL; Fung KP; Ooi VE; Waye MM
J Cell Biochem; 2006 Mar; 97(4):795-812. PubMed ID: 16237706
[TBL] [Abstract][Full Text] [Related]
24. [Inhibition of HBsAg and HBeAg secretion by RNA interference of the polymerase gene sequence of hepatitis B virus: an experimental study].
Liu SA; Wei HS; Dong QM; Guo JJ; Qin J; Zhang QY; Liu ZY; Yan J; Cheng J
Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(43):3079-83. PubMed ID: 16324412
[TBL] [Abstract][Full Text] [Related]
25. [Inhibitory effect of triplex forming oligodeoxynucleotides on HBV replication and synthesis of antigen].
Yang L; Chen Y; Gao Z
Zhonghua Gan Zang Bing Za Zhi; 1999 Mar; 7(1):8-10. PubMed ID: 10366973
[TBL] [Abstract][Full Text] [Related]
26. Liver-derived cell lines QSG-7701 and HepG2 support different HBV replication patterns.
Pan XB; Wei L; Chen HS; Liu F; Gao Y
Arch Virol; 2007; 152(6):1159-73. PubMed ID: 17308979
[TBL] [Abstract][Full Text] [Related]
27. [Study on the replication of Hepatitis B Virus in primary hepatocytes from heterogenous species].
Yao YQ; Zhang DF; Huang AL; Tang N; Wang B; Zhou WP; Ren H; Guo SH
Zhonghua Gan Zang Bing Za Zhi; 2004 Jan; 12(1):25-8. PubMed ID: 14761278
[TBL] [Abstract][Full Text] [Related]
28. In vivo and in vitro anti-hepatitis B virus activity of total phenolics from Oenanthe javanica.
Han YQ; Huang ZM; Yang XB; Liu HZ; Wu GX
J Ethnopharmacol; 2008 Jun; 118(1):148-53. PubMed ID: 18495393
[TBL] [Abstract][Full Text] [Related]
29. [Transfection of siRNA expressing plasmids targeting S gene inhibits replication and expression of hepatitis B virus in hepatic cancer cells].
Bian ZQ; Cui ZL; Chen WZ; Liu MQ; Yan WY; Zheng ZX
Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(5):347-51. PubMed ID: 19563716
[TBL] [Abstract][Full Text] [Related]
30. Adeno-associated virus Rep78 protein inhibits Hepatitis B virus replication through regulation of the HBV core promoter.
Liu T; Cong M; Wang P; Jia J; Liu Y; Hermonat PL; You H
Biochem Biophys Res Commun; 2009 Jul; 385(1):106-11. PubMed ID: 19410559
[TBL] [Abstract][Full Text] [Related]
31. The HBV-producing cell line HepG2-4A5: a new in vitro system for studying the regulation of HBV replication and for screening anti-hepatitis B virus drugs.
Weiss L; Kekulè AS; Jakubowski U; Bürgelt E; Hofschneider PH
Virology; 1996 Feb; 216(1):214-8. PubMed ID: 8614990
[TBL] [Abstract][Full Text] [Related]
32. Combination of small interfering RNAs mediates greater inhibition of human hepatitis B virus replication and antigen expression.
Chen Z; Xu ZF; Ye JJ; Yao HP; Zheng S; Ding JY
J Zhejiang Univ Sci B; 2005 Apr; 6(4):236-41. PubMed ID: 15754419
[TBL] [Abstract][Full Text] [Related]
33. [Comparisons of the characteristics and mechanisms of HBV replication in QSG-7701 and HepG2 cell lines].
Pan XB; Zhu L; Gao Y; Chen HS; Wei L
Zhonghua Gan Zang Bing Za Zhi; 2007 Feb; 15(2):83-7. PubMed ID: 17362629
[TBL] [Abstract][Full Text] [Related]
34. High level virion production and surface antigen expression with 1.5 copies of hepatitis B viral genome.
Dong Q; Liu Z; Chen Y; Chan CY; Lin MC; Kung HF; Chan HL; Sung JJ; He ML
J Virol Methods; 2009 Aug; 159(2):135-40. PubMed ID: 19490966
[TBL] [Abstract][Full Text] [Related]
35. Hepatitis B virus replication in human HepG2 cells mediated by hepatitis B virus recombinant baculovirus.
Delaney WE; Isom HC
Hepatology; 1998 Oct; 28(4):1134-46. PubMed ID: 9755254
[TBL] [Abstract][Full Text] [Related]
36. Whole genome expression profiling of hepatitis B virus-transfected cell line reveals the potential targets of anti-HBV drugs.
Ding XR; Yang J; Sun DC; Lou SK; Wang SQ
Pharmacogenomics J; 2008 Feb; 8(1):61-70. PubMed ID: 17505500
[TBL] [Abstract][Full Text] [Related]
37. [Study on anti-HBV effects by antisense oligodeoxynucleotides in vitro].
Liu S; Sun W; Cao Y
Zhonghua Yu Fang Yi Xue Za Zhi; 2001 Sep; 35(5):338-40. PubMed ID: 11769637
[TBL] [Abstract][Full Text] [Related]
38. Knockdown of HBV surface antigen gene expression by a lentiviral microRNA-based system inhibits HBV replication and HCC growth.
Xiangji L; Feng X; Qingbao C; Weifeng T; Xiaoqing J; Baihe Z; Feng S; Hongyang W; Mengchao W
J Viral Hepat; 2011 Sep; 18(9):653-60. PubMed ID: 20642484
[TBL] [Abstract][Full Text] [Related]
39. [Inhibition of hepatitis B viral gene expression and replication in vitro by targeted antisense oligonucleotides].
Zhong S; Zhang D; Wen S
Zhonghua Yi Xue Za Zhi; 1995 Jul; 75(7):392-5, 444. PubMed ID: 7553155
[TBL] [Abstract][Full Text] [Related]
40. [Synthesis of a novel L-nucleoside, beta-L-D4A and its inhibition on the replication of hepatitis B virus in vitro].
Wu JM; Lin JS; Xie N; Qiu GF; Hu XM
Yao Xue Xue Bao; 2005 Sep; 40(9):825-9. PubMed ID: 16342685
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
